Oncopeptides AB, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, announces that the number of shares and votes in Oncopeptides has changed due to the exercise of warrants under the company’s incentive program.
November 30, 2020
· 2 min read